OraSure Technologies Value Chain Analysis

OraSure Technologies Value Chain Analysis

Fully Editable

Tailor To Your Needs In Excel Or Sheets

Professional Design

Trusted, Industry-Standard Templates

Pre-Built

For Quick And Efficient Use

No Expertise Is Needed

Easy To Follow

OraSure Technologies Bundle

Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
Icon

Unlock the Full Value Chain Analysis for Deeper Insight

This OraSure Technologies Value Chain Analysis helps you quickly understand the company's support and primary activities in one structured format. This page already shows a real preview of the actual deliverable, so you can review the style and content before buying. Purchase the full version to get the complete ready-to-use analysis.

Support Activities

Icon

Firm Infrastructure

OraSure Technologies' firm infrastructure links finance, legal, quality, and compliance with regulated diagnostics and specimen collection, so product decisions stay aligned with FDA rules and market access. This matters because OraSure Technologies sells across consumer tests, professional channels, and research products, which means one control system must manage several risk profiles at once. In FY2025, that kind of governance protects margins by reducing recall, audit, and launch delays while keeping oversight tight across the full product line.

Icon

Human Resource Management

In FY2025, OraSure Technologies' Human Resource Management needs scientists, regulatory staff, quality teams, technicians, and commercial talent who can work in regulated diagnostics without breaking product consistency. Hiring and training matter because even small errors can affect collection devices, molecular tests, and customer trust. Cross-functional coordination also helps align R&D, manufacturing, and sales across different product needs.

Explore a Preview
Icon

Technology Development

OraSure Technologies' technology development centers on assay design, oral-fluid testing, sample stabilization chemistry, and easy collection formats. In FY2025, this R&D and validation work stayed central to improving accuracy, usability, and regulatory readiness across point-of-care and over-the-counter diagnostics. This is a key edge because better test performance and simpler use can support adoption and protect the value of proprietary platforms.

Icon

Procurement

Procurement at OraSure Technologies centers on reagents, plastics, membranes, swabs, tubes, packaging, and other controlled inputs. Tight supplier qualification and buying discipline help keep margins steady and lot-to-lot quality consistent across diagnostics and molecular collection products.

That matters in 2025 because even small input swings can hit gross margin and service levels, so reliable sourcing supports scale without adding rework or supply risk.

Icon
Icon

OraSure's FY2025 support engine kept quality, compliance, and margins in focus

OraSure Technologies' support activities in FY2025 stayed tied to compliance, skilled staffing, R&D, and disciplined sourcing, which is vital in regulated diagnostics. One control system had to support consumer tests, professional products, and research tools without breaking quality or supply. That mix makes overhead control and supplier quality central to margin protection.

Support activity FY2025 role
Infrastructure Finance, legal, quality, compliance
HR Scientists, regulatory, quality, commercial staff
Technology Assay design, oral-fluid testing, validation
Procurement Reagents, plastics, membranes, packaging

What is included in the product

Word Icon Detailed Word Document
Provides a clear framework for analyzing how OraSure Technologies creates value across its support functions and core operating activities
Plus Icon
Excel Icon Editable Excel File
OraSure Technologies Value Chain Analysis offers a clear, fast snapshot of key activities and value drivers, helping pinpoint operational pain points and improvement opportunities.

Primary Activities

Icon

Inbound Logistics

OraSure Technologies buys regulated raw materials, components, and packaging for diagnostic kits and collection devices, so inbound quality checks matter a lot. Incoming inspection helps catch defects before production starts, which is critical when kits must meet tight FDA and ISO-type quality controls. Careful inventory control also matters because many inputs are specialized and can have long lead times, so even a small supply slip can delay finished-unit output.

Icon

Operations

In FY2025, OraSure Technologies kept Operations focused on manufacturing, assembly, quality control, and final lot release for OTC, point-of-care, and research products. This stage turns specialized inputs into finished kits and tests, so batch reliability matters at every step. One missed release can delay sales and raise scrap costs.

Explore a Preview
Icon

Outbound Logistics

OraSure Technologies' outbound logistics moves finished products through direct fulfillment, distributors, and customer-specific shipping channels, so the team must match service levels to consumer, healthcare, and research buyers. In 2025, this matters because the company still serves a broad diagnostics and sample collection base, where late or wrong shipments can hit availability fast. Tight shipping execution protects fill rates, shortens order cycles, and keeps customer service steady.

Icon

Marketing and Sales

In 2025, OraSure Technologies used marketing and sales to link its diagnostics to consumers, providers, public health buyers, and research labs, so product education and channel control mattered as much as the product itself. Buyers that see clear ease of use and clinical value are more likely to adopt tests and collection tools, which helps convert demand into revenue.

  • Education supports adoption
  • Evidence drives buying decisions
  • Channel reach shapes revenue
Icon

Service

OraSure Technologies' service work covers training, order support, complaint handling, and post-market surveillance, which matters in regulated diagnostics where one support miss can damage trust fast. This activity helps protect repeat use and also feeds field issues back into product design and documentation, so new kits and instructions match real-world use better.

Icon

OraSure Technologies: FY2025 Focus on Quality, Fulfillment, and Adoption

In FY2025, OraSure Technologies' primary activities centered on making regulated diagnostics, releasing lots, and shipping finished kits on time. Marketing and service then supported adoption, complaint handling, and post-market feedback, which helped protect repeat use.

Primary activity FY2025 role
Operations Manufacture and lot release
Outbound logistics Direct fulfillment

Preview the Actual Deliverable
OraSure Technologies Reference Sources

This is the actual OraSure Technologies Value Chain Analysis document you'll receive upon purchase – no surprises, just the full professional version. The preview below is taken directly from the complete report, so what you see is what you get. Once purchased, the full detailed document is unlocked immediately for download.

Explore a Preview

Frequently Asked Questions

OraSure Technologies prioritizes regulated product development, manufacturing reliability, and channel access. Its value chain is built around 2 product families-diagnostics and molecular collection-served by 4 support activities and 5 primary activities. That structure helps OraSure Technologies balance consumer OTC tests, professional point-of-care products, and research collection devices.

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.